Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Net Margin (2020 - 2022)

Historic Net Margin for SELLAS Life Sciences (SLS) over the last 4 years, with Q1 2022 value amounting to 1673.5%.

  • SELLAS Life Sciences' Net Margin fell 16313400.0% to 1673.5% in Q1 2022 from the same period last year, while for Dec 2022 it was 4195.0%, marking a year-over-year decrease of 39226400.0%. This contributed to the annual value of 4130.1% for FY2022, which is 38577400.0% down from last year.
  • Latest data reveals that SELLAS Life Sciences reported Net Margin of 1673.5% as of Q1 2022, which was down 16313400.0% from 242.79% recorded in Q2 2021.
  • SELLAS Life Sciences' Net Margin's 5-year high stood at 42.16% during Q1 2021, with a 5-year trough of 1673.5% in Q1 2022.
  • Moreover, its 3-year median value for Net Margin was 219.18% (2020), whereas its average is 538.51%.
  • The largest annual percentage gain for SELLAS Life Sciences' Net Margin in the last 5 years was -16313400bps (2022), contrasted with its biggest fall of -16313400bps (2022).
  • Quarter analysis of 3 years shows SELLAS Life Sciences' Net Margin stood at 195.58% in 2020, then dropped by -24bps to 242.79% in 2021, then plummeted by -589bps to 1673.5% in 2022.
  • Its last three reported values are 1673.5% in Q1 2022, 242.79% for Q2 2021, and 42.16% during Q1 2021.